{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:08:19Z","timestamp":1781626099181,"version":"3.54.5"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["82400418"],"award-info":[{"award-number":["82400418"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["82203190"],"award-info":[{"award-number":["82203190"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Innovation Capacity Support Program of Shaanxi Province","award":["2023-CX-TD-76"],"award-info":[{"award-number":["2023-CX-TD-76"]}]},{"name":"the Health Research and Innovation Capacity Enhancement Program of Shaanxi Province","award":["2023PT-10"],"award-info":[{"award-number":["2023PT-10"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Vitamin C (VC) is a water-soluble, essential micronutrient with multiple important physiological functions. Numerous studies have shown that VC deficiency is closely associated with adverse clinical outcomes in critically ill patients. Due to the extreme oxidative stress and inflammatory response associated with sepsis and its complications, which lead to a rapid depletion of VC. This study aims to explore whether VC supplementation can reduce the mortality of patients with sepsis-induced myocardial injury (SIMI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study used the MIMIC-IV database to extract data of patients with SIMI and conducted a retrospective cohort study. The patients were divided into the VC administration group (VC group) and the non-VC administration group (non-VC group). The study adopted the multiple imputation method to handle the missing data and balanced the baseline characteristics between the two groups using propensity score matching (PSM). The primary outcome was 28-day all-cause mortality, and the secondary outcome included 90-day and 1-year all-cause mortality. Univariate and multivariable Cox proportional hazards regression models were used to evaluate the association between VC administration and mortality in patients with SIMI, and further analyzed the impact of VC dosage on clinical outcomes. The results were visualized using Kaplan-Meier survival curve. Subgroup analysis was conducted to explore the differences in therapeutic efficacy of VC among different populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      There were a total of 1488 patients in the final cohort who met the SIMI criteria. After PSM, 129 patients who received VC were matched with 129 non-VC patients. Kaplan-Meier survival curve analysis showed that the VC group had significantly reduced mortality rates at 28 days (27.132% vs. 9.302%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), 90 days (33.333% vs. 16.279%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and 1 year (44.186% vs. 27.132%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Multivariable Cox regression analysis further confirmed that VC administration significantly reduced 28-day (HR\u2009=\u20090.20, 95% CI [0.10, 0.41]), 90-day (HR\u2009=\u20090.25, 95% CI [0.14, 0.43]) and 1-year mortality risk (HR\u2009=\u20090.32, 95% CI [0.20, 0.50]). Regarding dosage, the 28-day and 90-day mortality of SIMI patients in the high-dose group were obviously lower than those in the low-dose group, whereas no significant difference was observed in 1-year mortality between the two groups. Subgroup analysis showed a consistent benefit of VC across most populations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The administration of VC was associated with significantly reduced 28-day, 90-day, and 1-year mortality in patients with SIMI, and high-dose group conferred a greater benefit than low-dose group in the short term.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-025-12377-1","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T11:54:05Z","timestamp":1766577245000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vitamin C is associated with improved outcomes in patients with sepsis-induced myocardial injury: insights from the MIMIC-IV database"],"prefix":"10.1186","volume":"26","author":[{"given":"Rui","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zifeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"issue":"8","key":"12377_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801\u201310.","journal-title":"JAMA"},{"key":"12377_CR2","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jcrc.2017.09.031","volume":"43","author":"J Teng","year":"2018","unstructured":"Teng J, Pourmand A, Mazer-Amirshahi M, Vitamin C. The next step in sepsis management? J Crit Care. 2018;43:230\u20134.","journal-title":"J Crit Care"},{"issue":"7","key":"12377_CR3","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41581-018-0005-7","volume":"14","author":"C Lelubre","year":"2018","unstructured":"Lelubre C, Vincent JL. Mechanisms and treatment of organ failure in sepsis. Nat Rev Nephrol. 2018;14(7):417\u201327.","journal-title":"Nat Rev Nephrol"},{"key":"12377_CR4","doi-asserted-by":"publisher","first-page":"1520107","DOI":"10.3389\/fphar.2025.1520107","volume":"16","author":"Y Liu","year":"2025","unstructured":"Liu Y, Chen J, Yuan Y, Niu P, Wu M, Shang B, Lu W, Zou X, Yao G. Impact of Statin use on short- and long-term outcomes in patients with sepsis-induced myocardial injury: insights from the MIMIC-IV database. Front Pharmacol. 2025;16:1520107.","journal-title":"Front Pharmacol"},{"issue":"8","key":"12377_CR5","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1007\/s00134-020-06151-x","volume":"46","author":"C Fleischmann-Struzek","year":"2020","unstructured":"Fleischmann-Struzek C, Mellhammar L, Rose N, Cassini A, Rudd KE, Schlattmann P, Allegranzi B, Reinhart K. Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis. Intensive Care Med. 2020;46(8):1552\u201362.","journal-title":"Intensive Care Med"},{"issue":"9","key":"12377_CR6","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1097\/00003246-199909000-00012","volume":"27","author":"A Turner","year":"1999","unstructured":"Turner A, Tsamitros M, Bellomo R. Myocardial cell injury in septic shock. Crit Care Med. 1999;27(9):1775\u201380.","journal-title":"Crit Care Med"},{"issue":"2","key":"12377_CR7","doi-asserted-by":"publisher","first-page":"e004040","DOI":"10.1161\/CIRCOUTCOMES.117.004040","volume":"11","author":"JF Frencken","year":"2018","unstructured":"Frencken JF, Donker DW, Spitoni C, Koster-Brouwer ME, Soliman IW, Ong DSY, Horn J, van der Poll T, van Klei WA, Bonten MJM, et al. Myocardial injury in patients with sepsis and its association with Long-Term outcome. Circulation Cardiovasc Qual Outcomes. 2018;11(2):e004040.","journal-title":"Circulation Cardiovasc Qual Outcomes"},{"issue":"11","key":"12377_CR8","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, Machado FR, McIntyre L, Ostermann M, Prescott HC, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181\u2013247.","journal-title":"Intensive Care Med"},{"issue":"16","key":"12377_CR9","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1001\/jama.2013.278477","volume":"310","author":"A Morelli","year":"2013","unstructured":"Morelli A, Ertmer C, Westphal M, Rehberg S, Kampmeier T, Ligges S, Orecchioni A, D\u2019Egidio A, D\u2019Ippoliti F, Raffone C, et al. Effect of heart rate control with Esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA. 2013;310(16):1683\u201391.","journal-title":"JAMA"},{"issue":"17","key":"12377_CR10","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1056\/NEJMoa1609409","volume":"375","author":"AC Gordon","year":"2016","unstructured":"Gordon AC, Perkins GD, Singer M, McAuley DF, Orme RM, Santhakumaran S, Mason AJ, Cross M, Al-Beidh F, Best-Lane J, et al. Levosimendan for the prevention of acute organ dysfunction in sepsis. N Engl J Med. 2016;375(17):1638\u201348.","journal-title":"N Engl J Med"},{"issue":"6","key":"12377_CR11","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41569-020-00492-2","volume":"18","author":"SM Hollenberg","year":"2021","unstructured":"Hollenberg SM, Singer M. Pathophysiology of sepsis-induced cardiomyopathy. Nat Reviews Cardiol. 2021;18(6):424\u201334.","journal-title":"Nat Reviews Cardiol"},{"issue":"4","key":"12377_CR12","doi-asserted-by":"publisher","first-page":"e10128","DOI":"10.15252\/emmm.201810128","volume":"12","author":"JM Cavaillon","year":"2020","unstructured":"Cavaillon JM, Singer M, Skirecki T. Sepsis therapies: learning from 30 years of failure of translational research to propose new leads. EMBO Mol Med. 2020;12(4):e10128.","journal-title":"EMBO Mol Med"},{"issue":"3","key":"12377_CR13","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.cmi.2018.11.003","volume":"25","author":"B Pertzov","year":"2019","unstructured":"Pertzov B, Eliakim-Raz N, Atamna H, Trestioreanu AZ, Yahav D, Leibovici L. Hydroxymethylglutaryl-CoA reductase inhibitors (statins) for the treatment of sepsis in adults - A systematic review and meta-analysis. Clin Microbiol Infection: Official Publication Eur Soc Clin Microbiol Infect Dis. 2019;25(3):280\u20139.","journal-title":"Clin Microbiol Infection: Official Publication Eur Soc Clin Microbiol Infect Dis"},{"issue":"1","key":"12377_CR14","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3892\/mmr.2020.11114","volume":"22","author":"C Wang","year":"2020","unstructured":"Wang C, Yuan W, Hu A, Lin J, Xia Z, Yang CF, Li Y, Zhang Z. Dexmedetomidine alleviated sepsis\u2013induced myocardial ferroptosis and septic heart injury. Mol Med Rep. 2020;22(1):175\u201384.","journal-title":"Mol Med Rep"},{"key":"12377_CR15","doi-asserted-by":"crossref","unstructured":"Fisher BJ, Kraskauskas D, Martin EJ, Farkas D, Puri P, Massey HD, Idowu MO, Brophy DF, Voelkel NF, Fowler AA 3, et al. Attenuation of sepsis-induced organ injury in mice by vitamin C. JPEN J Parenter Enter Nutr. 2014;38(7):825\u201339.","DOI":"10.1177\/0148607113497760"},{"issue":"8","key":"12377_CR16","first-page":"6937","volume":"16","author":"YN Cui","year":"2024","unstructured":"Cui YN, Tian N, Luo YH, Zhao JJ, Bi CF, Gou Y, Liu J, Feng K, Zhang JF. High-dose vitamin C injection ameliorates against sepsis-induced myocardial injury by anti-apoptosis, anti-inflammatory and pro-autophagy through regulating MAPK, NF-\u03baB and PI3K\/AKT\/mTOR signaling pathways in rats. Aging. 2024;16(8):6937\u201353.","journal-title":"Aging"},{"issue":"6","key":"12377_CR17","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.chest.2016.11.036","volume":"151","author":"PE Marik","year":"2017","unstructured":"Marik PE, Khangoora V, Rivera R, Hooper MH, Catravas J. Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: A retrospective Before-After study. Chest. 2017;151(6):1229\u201338.","journal-title":"Chest"},{"issue":"11","key":"12377_CR18","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1007\/s00134-018-5107-y","volume":"44","author":"K Amrein","year":"2018","unstructured":"Amrein K, Oudemans-van Straaten HM, Berger MM. Vitamin therapy in critically ill patients: focus on thiamine, vitamin C, and vitamin D. Intensive Care Med. 2018;44(11):1940\u20134.","journal-title":"Intensive Care Med"},{"key":"12377_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.pharmthera.2018.04.007","volume":"189","author":"PE Marik","year":"2018","unstructured":"Marik PE. Vitamin C for the treatment of sepsis: the scientific rationale. Pharmacol Ther. 2018;189:63\u201370.","journal-title":"Pharmacol Ther"},{"key":"12377_CR20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jcrc.2019.12.011","volume":"57","author":"J Obi","year":"2020","unstructured":"Obi J, Pastores SM, Ramanathan LV, Yang J, Halpern NA. Treating sepsis with vitamin C, thiamine, and hydrocortisone: exploring the quest for the magic elixir. J Crit Care. 2020;57:231\u20139.","journal-title":"J Crit Care"},{"issue":"1","key":"12377_CR21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s13054-018-2217-4","volume":"22","author":"A Moskowitz","year":"2018","unstructured":"Moskowitz A, Andersen LW, Huang DT, Berg KM, Grossestreuer AV, Marik PE, Sherwin RL, Hou PC, Becker LB, Cocchi MN, et al. Ascorbic acid, corticosteroids, and thiamine in sepsis: a review of the biologic rationale and the present state of clinical evaluation. Crit Care (London England). 2018;22(1):283.","journal-title":"Crit Care (London England)"},{"key":"12377_CR22","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1479-5876-12-32","volume":"12","author":"AA Fowler","year":"2014","unstructured":"Fowler AA 3rd, Syed AA, Knowlson S, Sculthorpe R, Farthing D, DeWilde C, Farthing CA, Larus TL, Martin E, Brophy DF, et al. Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis. J Translational Med. 2014;12:32.","journal-title":"J Translational Med"},{"issue":"2","key":"12377_CR23","doi-asserted-by":"publisher","first-page":"94","DOI":"10.4103\/2279-042X.179569","volume":"5","author":"MH Zabet","year":"2016","unstructured":"Zabet MH, Mohammadi M, Ramezani M, Khalili H. Effect of high-dose ascorbic acid on vasopressor\u2019s requirement in septic shock. J Res Pharm Pract. 2016;5(2):94\u2013100.","journal-title":"J Res Pharm Pract"},{"issue":"1","key":"12377_CR24","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s13054-018-2191-x","volume":"22","author":"J Li","year":"2018","unstructured":"Li J. Evidence is stronger than you think: a meta-analysis of vitamin C use in patients with sepsis. Crit Care (London England). 2018;22(1):258.","journal-title":"Crit Care (London England)"},{"issue":"5","key":"12377_CR25","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.amjmed.2019.07.054","volume":"133","author":"AB Mitchell","year":"2020","unstructured":"Mitchell AB, Ryan TE, Gillion AR, Wells LD, Muthiah MP. Vitamin C and thiamine for sepsis and septic shock. Am J Med. 2020;133(5):635\u20138.","journal-title":"Am J Med"},{"issue":"7","key":"12377_CR26","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1001\/jama.2020.11946","volume":"324","author":"A Moskowitz","year":"2020","unstructured":"Moskowitz A, Huang DT, Hou PC, Gong J, Doshi PB, Grossestreuer AV, Andersen LW, Ngo L, Sherwin RL, Berg KM, et al. Effect of ascorbic Acid, Corticosteroids, and thiamine on organ injury in septic shock: the ACTS randomized clinical trial. JAMA. 2020;324(7):642\u201350.","journal-title":"JAMA"},{"issue":"8","key":"12377_CR27","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1001\/jama.2020.24505","volume":"325","author":"JE Sevransky","year":"2021","unstructured":"Sevransky JE, Rothman RE, Hager DN, Bernard GR, Brown SM, Buchman TG, Busse LW, Coopersmith CM, DeWilde C, Ely EW, et al. Effect of vitamin C, Thiamine, and hydrocortisone on Ventilator- and Vasopressor-Free days in patients with sepsis: the VICTAS randomized clinical trial. JAMA. 2021;325(8):742\u201350.","journal-title":"JAMA"},{"issue":"13","key":"12377_CR28","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1001\/jama.2019.11825","volume":"322","author":"AA Fowler","year":"2019","unstructured":"Fowler AA 3rd, Truwit JD, Hite RD, Morris PE, DeWilde C, Priday A, Fisher B, Thacker LR 2nd, Natarajan R, Brophy DF, et al. Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: the CITRIS-ALI randomized clinical trial. JAMA. 2019;322(13):1261\u201370.","journal-title":"JAMA"},{"issue":"5","key":"12377_CR29","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1001\/jama.2019.22176","volume":"323","author":"T Fujii","year":"2020","unstructured":"Fujii T, Luethi N, Young PJ, Frei DR, Eastwood GM, French CJ, Deane AM, Shehabi Y, Hajjar LA, Oliveira G, et al. Effect of vitamin C, hydrocortisone, and thiamine vs hydrocortisone alone on time alive and free of vasopressor support among patients with septic shock: the VITAMINS randomized clinical trial. JAMA. 2020;323(5):423\u201331.","journal-title":"JAMA"},{"issue":"25","key":"12377_CR30","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1056\/NEJMoa2200644","volume":"386","author":"F Lamontagne","year":"2022","unstructured":"Lamontagne F, Masse MH, Menard J, Sprague S, Pinto R, Heyland DK, Cook DJ, Battista MC, Day AG, Guyatt GH, et al. Intravenous vitamin C in adults with sepsis in the intensive care unit. N Engl J Med. 2022;386(25):2387\u201398.","journal-title":"N Engl J Med"},{"issue":"3","key":"12377_CR31","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1097\/00003246-199603000-00006","volume":"24","author":"E Borrelli","year":"1996","unstructured":"Borrelli E, Roux-Lombard P, Grau GE, Girardin E, Ricou B, Dayer J, Suter PM. Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit Care Med. 1996;24(3):392\u20137.","journal-title":"Crit Care Med"},{"issue":"2","key":"12377_CR32","doi-asserted-by":"publisher","first-page":"e179","DOI":"10.1097\/CCM.0000000000004770","volume":"49","author":"YR Lankadeva","year":"2021","unstructured":"Lankadeva YR, Peiris RM, Okazaki N, Birchall IE, Trask-Marino A, Dornom A, Vale TAM, Evans RG, Yanase F, Bellomo R, et al. Reversal of the pathophysiological responses to Gram-Negative sepsis by megadose vitamin C. Crit Care Med. 2021;49(2):e179\u201390.","journal-title":"Crit Care Med"},{"key":"12377_CR33","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.2147\/IJGM.S318232","volume":"14","author":"R Xie","year":"2021","unstructured":"Xie R, Chen Q, He W, Zeng M. Association of cardiac troponin T concentration on admission with prognosis in critically ill patients without myocardial infarction: A cohort study. Int J Gen Med. 2021;14:2729\u201339.","journal-title":"Int J Gen Med"},{"key":"12377_CR34","doi-asserted-by":"crossref","unstructured":"Vallabhajosyula S, Sakhuja A, Geske JB, Kumar M, Poterucha JT, Kashyap R, Kashani K, Jaffe AS, Jentzer JC. Role of admission Troponin-T and serial Troponin-T testing in predicting outcomes in severe sepsis and septic shock. J Am Heart Association. 2017;6(9).","DOI":"10.1161\/JAHA.117.005930"},{"key":"12377_CR35","doi-asserted-by":"publisher","first-page":"111597","DOI":"10.1016\/j.jclinane.2024.111597","volume":"99","author":"Y Dong","year":"2024","unstructured":"Dong Y, Wei S, Liu Y, Ji X, Yin X, Wu Z, Wu S, Wang B, Wei S, Chen Y. Aspirin is associated with improved outcomes in patients with sepsis-induced myocardial injury: an analysis of the MIMIC-IV database. J Clin Anesth. 2024;99:111597.","journal-title":"J Clin Anesth"},{"issue":"1","key":"12377_CR36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s00134-021-06558-0","volume":"48","author":"T Fujii","year":"2022","unstructured":"Fujii T, Salanti G, Belletti A, Bellomo R, Carr A, Furukawa TA, Luethi N, Luo Y, Putzu A, Sartini C, et al. Effect of adjunctive vitamin C, glucocorticoids, and vitamin B1 on longer-term mortality in adults with sepsis or septic shock: a systematic review and a component network meta-analysis. Intensive Care Med. 2022;48(1):16\u201324.","journal-title":"Intensive Care Med"},{"issue":"42","key":"12377_CR37","doi-asserted-by":"publisher","first-page":"e35648","DOI":"10.1097\/MD.0000000000035648","volume":"102","author":"Y Zeng","year":"2023","unstructured":"Zeng Y, Liu Z, Xu F, Tang Z. Intravenous high-dose vitamin C monotherapy for sepsis and septic shock: A meta-analysis of randomized controlled trials. Medicine. 2023;102(42):e35648.","journal-title":"Medicine"},{"issue":"1","key":"12377_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.21037\/atm.2016.08.57","volume":"5","author":"Z Zhang","year":"2017","unstructured":"Zhang Z. Propensity score method: a non-parametric technique to reduce model dependence. Annals Translational Med. 2017;5(1):7.","journal-title":"Annals Translational Med"},{"issue":"1","key":"12377_CR39","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s13054-017-1891-y","volume":"21","author":"AC Carr","year":"2017","unstructured":"Carr AC, Rosengrave PC, Bayer S, Chambers S, Mehrtens J, Shaw GM. Hypovitaminosis C and vitamin C deficiency in critically ill patients despite recommended enteral and parenteral intakes. Crit Care (London England). 2017;21(1):300.","journal-title":"Crit Care (London England)"},{"key":"12377_CR40","doi-asserted-by":"crossref","unstructured":"Kayki Mutlu G, Koch WJ. Linking phospholipid metabolism to septic cardiomyopathy via HIF-1\u03b1 overactivation. Nat Cardiovasc Res. 2025;4(9):1036\u201337.","DOI":"10.1038\/s44161-025-00680-8"},{"key":"12377_CR41","doi-asserted-by":"crossref","unstructured":"Watanabe M, Ikeda M, Abe K, Furusawa S, Ishimaru K, Kanamura T, Fujita S, Miyamoto HD, Kozakura E, Isayama YS et al. Excessive HIF-1\u03b1 driven by phospholipid metabolism causes septic cardiomyopathy through cytopathic hypoxia. Nat Cardiovasc Res. 2025;4(9):1077\u201393.","DOI":"10.1038\/s44161-025-00687-1"},{"key":"12377_CR42","doi-asserted-by":"crossref","unstructured":"Gao L, Shi Q, Sun B, Zhang X, Zheng P, Zhou L, Tian G, Li H. c-FLIP protects cardiac microcirculation in sepsis-induced myocardial dysfunction via FUNDC1-Mediated regulation of mitochondrial autophagy. JACC Basic Translational Sci. 2025;10(8):101257.","DOI":"10.1016\/j.jacbts.2025.02.016"},{"issue":"2","key":"12377_CR43","first-page":"443","volume":"1826","author":"J Du","year":"2012","unstructured":"Du J, Cullen JJ, Buettner GR. Ascorbic acid: chemistry, biology and the treatment of cancer. Biochim Biophys Acta. 2012;1826(2):443\u201357.","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"12377_CR44","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1080\/10739680701410389","volume":"14","author":"RL McKinnon","year":"2007","unstructured":"McKinnon RL, Lidington D, Tyml K. Ascorbate inhibits reduced arteriolar conducted vasoconstriction in septic mouse cremaster muscle. Microcirculation (New York NY: 1994). 2007;14(7):697\u2013707.","journal-title":"Microcirculation (New York NY: 1994)"},{"issue":"3","key":"12377_CR45","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1152\/jappl.2001.90.3.795","volume":"90","author":"J Armour","year":"2001","unstructured":"Armour J, Tyml K, Lidington D, Wilson JX. Ascorbate prevents microvascular dysfunction in the skeletal muscle of the septic rat. J Appl Physiol (Bethesda Md: 1985). 2001;90(3):795\u2013803.","journal-title":"J Appl Physiol (Bethesda Md: 1985)"},{"key":"12377_CR46","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1186\/s13054-015-1131-2","volume":"19","author":"AC Carr","year":"2015","unstructured":"Carr AC, Shaw GM, Fowler AA, Natarajan R. Ascorbate-dependent vasopressor synthesis: a rationale for vitamin C administration in severe sepsis and septic shock? Crit Care (London England). 2015;19:418.","journal-title":"Crit Care (London England)"},{"key":"12377_CR47","doi-asserted-by":"crossref","unstructured":"Holford P, Carr AC, Jovic TH, Ali SR, Whitaker IS, Marik PE, Smith AD. Vitamin C-An adjunctive therapy for respiratory infection, sepsis and COVID-19. Nutrients. 2020;12(12).","DOI":"10.3390\/nu12123760"},{"issue":"4","key":"12377_CR48","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/embor.2013.29","volume":"14","author":"A Monfort","year":"2013","unstructured":"Monfort A, Wutz A. Breathing-in epigenetic change with vitamin C. EMBO Rep. 2013;14(4):337\u201346.","journal-title":"EMBO Rep"},{"key":"12377_CR49","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1146\/annurev-nutr-071714-034228","volume":"35","author":"JI Young","year":"2015","unstructured":"Young JI, Z\u00fcchner S, Wang G. Regulation of the epigenome by vitamin C. Annu Rev Nutr. 2015;35:545\u201364.","journal-title":"Annu Rev Nutr"},{"key":"12377_CR50","unstructured":"Abdullah M, Jamil RT, Attia FN. Vitamin C (Ascorbic Acid). In: StatPearls. edn. Treasure Island (FL) ineligible companies. Disclosure: Radia Jamil declares no relevant financial relationships with ineligible companies. Disclosure: Fibi Attia declares no relevant financial relationships with ineligible companies.: StatPearls Publishing Copyright \u00a9 2025, StatPearls Publishing LLC.; 2025."},{"issue":"7","key":"12377_CR51","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1080\/10715760290032557","volume":"36","author":"K Voigt","year":"2002","unstructured":"Voigt K, Kontush A, Stuerenburg HJ, Muench-Harrach D, Hansen HC, Kunze K. Decreased plasma and cerebrospinal fluid ascorbate levels in patients with septic encephalopathy. Free Radic Res. 2002;36(7):735\u20139.","journal-title":"Free Radic Res"},{"key":"12377_CR52","doi-asserted-by":"crossref","unstructured":"Marik PE. Hydrocortisone, ascorbic acid and thiamine (HAT Therapy) for the treatment of sepsis. Focus on ascorbic acid. Nutrients. 2018;10(11).","DOI":"10.3390\/nu10111762"},{"key":"12377_CR53","doi-asserted-by":"crossref","unstructured":"Carr AC, Taylor, Francis collection of health research council of New Zealand. & funded monographs and chapters Vitamin C in pneumonia and sepsis. In: Vitamin C: new biochemical and functional insights. edn. Edited by Chen Q, Vissers MCM. Boca Raton (FL): CRC Press \u00a9 2020 by Taylor & Francis Group, LLC.; 2020: 115\u2013135.","DOI":"10.1201\/9780429442025-7"},{"issue":"10","key":"12377_CR54","first-page":"427","volume":"30","author":"N Jiang","year":"2024","unstructured":"Jiang N, Li N, Huang J, Ning K, Zhang H, Gou H, Zhang R. Impact of vitamin C on inflammatory response and myocardial injury in sepsis patients. Altern Ther Health Med. 2024;30(10):427\u201331.","journal-title":"Altern Ther Health Med"},{"key":"12377_CR55","doi-asserted-by":"publisher","first-page":"1600224","DOI":"10.3389\/fnut.2025.1600224","volume":"12","author":"Y He","year":"2025","unstructured":"He Y, Liu J. Vitamin C improves 28-day survival in patients with sepsis-associated acute kidney injury in the intensive care unit: a retrospective study. Front Nutr. 2025;12:1600224.","journal-title":"Front Nutr"},{"issue":"1","key":"12377_CR56","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13054-023-04392-y","volume":"27","author":"B Liang","year":"2023","unstructured":"Liang B, Su J, Shao H, Chen H, Xie B. The outcome of IV vitamin C therapy in patients with sepsis or septic shock: a meta-analysis of randomized controlled trials. Crit Care (London England). 2023;27(1):109.","journal-title":"Crit Care (London England)"},{"issue":"12","key":"12377_CR57","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1097\/CCM.0000000000005263","volume":"49","author":"R Sato","year":"2021","unstructured":"Sato R, Hasegawa D, Prasitlumkum N, Ueoka M, Nishida K, Takahashi K, Nasu M, Dugar S. Effect of IV High-Dose vitamin C on mortality in patients with sepsis: A systematic review and Meta-Analysis of randomized controlled trials. Crit Care Med. 2021;49(12):2121\u201330.","journal-title":"Crit Care Med"},{"issue":"1","key":"12377_CR58","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s00134-024-07733-9","volume":"51","author":"J Rynne","year":"2025","unstructured":"Rynne J, Mosavie M, Masse MH, M\u00e9nard J, Battista MC, Maslove DM, Del Sorbo L, St-Arnaud C, Fox-Robichaud FDA. Sepsis subtypes and differential treatment response to vitamin C: biological sub-study of the LOVIT trial. Intensive Care Med. 2025;51(1):82\u201393.","journal-title":"Intensive Care Med"},{"issue":"11","key":"12377_CR59","doi-asserted-by":"publisher","first-page":"e0259699","DOI":"10.1371\/journal.pone.0259699","volume":"16","author":"S Vandervelden","year":"2021","unstructured":"Vandervelden S, Wauters L, Breuls J, Fieuws S, Vanhove P, Hubloue I, Bartiaux M, Creteur J, Stifkens F, Monsieurs K, et al. Early administration of vitamin C in patients with sepsis or septic shock in emergency departments: A multicenter, double blinded, randomized controlled trial: the C-EASIE trial protocol. PLoS ONE. 2021;16(11):e0259699.","journal-title":"PLoS ONE"},{"issue":"4","key":"12377_CR60","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/S1441-2772(23)00548-3","volume":"21","author":"EP Hudson","year":"2019","unstructured":"Hudson EP, Collie JT, Fujii T, Luethi N, Udy AA, Doherty S, Eastwood G, Yanase F, Naorungroj T, Bitker L, et al. Pharmacokinetic data support 6-hourly dosing of intravenous vitamin C to critically ill patients with septic shock. Crit Care Resuscitation: J Australasian Acad Crit Care Med. 2019;21(4):236\u201342.","journal-title":"Crit Care Resuscitation: J Australasian Acad Crit Care Med"},{"issue":"8","key":"12377_CR61","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1164\/rccm.201807-1419OC","volume":"199","author":"DB Antcliffe","year":"2019","unstructured":"Antcliffe DB, Burnham KL, Al-Beidh F, Santhakumaran S, Brett SJ, Hinds CJ, Ashby D, Knight JC, Gordon AC. Transcriptomic signatures in sepsis and a differential response to Steroids. From the VANISH randomized trial. Am J Respir Crit Care Med. 2019;199(8):980\u20136.","journal-title":"Am J Respir Crit Care Med"},{"key":"12377_CR62","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1742-4933-7-7","volume":"7","author":"J Ongr\u00e1di","year":"2010","unstructured":"Ongr\u00e1di J, K\u00f6vesdi V. Factors that May impact on immunosenescence: an appraisal. Immun Ageing. 2010;7:7.","journal-title":"Immun Ageing."},{"issue":"1","key":"12377_CR63","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/01.CCM.0000194535.82812.BA","volume":"34","author":"GS Martin","year":"2006","unstructured":"Martin GS, Mannino DM, Moss M. The effect of age on the development and outcome of adult sepsis. Crit Care Med. 2006;34(1):15\u201321.","journal-title":"Crit Care Med"},{"issue":"16","key":"12377_CR64","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1089\/ars.2021.0056","volume":"35","author":"MS Kingren","year":"2021","unstructured":"Kingren MS, Starr ME, Saito H. Divergent sepsis pathophysiology in older adults. Antioxid Redox Signal. 2021;35(16):1358\u201375.","journal-title":"Antioxid Redox Signal"},{"issue":"3","key":"12377_CR65","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1093\/ndt\/17.3.422","volume":"17","author":"M Morena","year":"2002","unstructured":"Morena M, Cristol JP, Bosc JY, Tetta C, Forret G, Leger CL, Delcourt C, Papoz L, Descomps B, Canaud B. Convective and diffusive losses of vitamin C during haemodiafiltration session: a contributive factor to oxidative stress in haemodialysis patients. Nephrol Dialysis Transplantation: Official Publication Eur Dialysis Transpl Association - Eur Ren Association. 2002;17(3):422\u20137.","journal-title":"Nephrol Dialysis Transplantation: Official Publication Eur Dialysis Transpl Association - Eur Ren Association"},{"issue":"1","key":"12377_CR66","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s13054-018-2115-9","volume":"22","author":"PM Honore","year":"2018","unstructured":"Honore PM, De Bels D, Preseau T, Redant S, Attou R, Spapen HD. Adjuvant vitamin C in cardiac arrest patients undergoing renal replacement therapy: an appeal for a higher high-dose. Crit Care (London England). 2018;22(1):207.","journal-title":"Crit Care (London England)"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12377-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12377-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12377-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:45:51Z","timestamp":1781624751000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12377-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12377"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12377-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]},"assertion":[{"value":"9 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The database used in this study has been approved by the Institutional Review Board (IRB) at the Beth Israel Deaconess Medical Center (BIDMC). The researchers have completed the required online course study and obtained the database access qualification certification (certification number: 74469213). All projects do not involve the collection of individual informed consent, as the information used has already been de-identified. This study was conducted in accordance with the relevant ethical principles stated in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"171"}}